Parc Sanitari Sant Joan de Déu, Fundació Sant Joan de Déu, Sant Boi de Llobregat, Barcelona, Spain.
Qual Life Res. 2010 Feb;19(1):97-101. doi: 10.1007/s11136-009-9566-z. Epub 2009 Dec 18.
The 12-item WHO-DAS II was developed to assess the activity limitations and participation restrictions experienced by individuals irrespective of medical diagnosis. In this paper we examine the known-groups' validity of the instrument by evaluating its ability to discriminate between patients with/without major depression, patients with depression with/without medical comorbidity, and patients with depression with different depression severity.
The participants were 3,615 PC patients from 17 regions of Spain, with a first-time diagnosis of major depressive episode according to the general practitioner. The 12-item WHO-DAS II, the PHQ-9, and a chronic medical conditions checklist were administered during the consultation.
The statistical analyses indicated that the 12-item WHO-DAS II was able to discriminate between patients with/without depression and between those with different depression severity. The ROC analysis revealed that with a cutoff score >or=50, the instrument correctly classified 70.4% of the sample (area under the ROC curve = .76; sensitivity = 71.4%; specificity = 67.6%).
Overall, our results support the discriminant validity of the 12-item WHO-DAS II for major depression, being quite recommendable its use in epidemiological research.
12 项世界卫生组织残疾评定量表第二版(WHO-DAS II)旨在评估个体的活动受限和参与受限情况,无论其医疗诊断如何。本文通过评估其区分有/无重度抑郁症患者、有合并症/无合并症抑郁症患者以及不同严重程度抑郁症患者的能力,考察了该工具的已知群组有效性。
参与者为来自西班牙 17 个地区的 3615 名首发重性抑郁障碍患者,由全科医生进行诊断。在就诊时对患者进行 12 项世界卫生组织残疾评定量表第二版、PHQ-9 量表和慢性医疗条件检查表评估。
统计分析表明,12 项世界卫生组织残疾评定量表第二版能够区分有/无抑郁症患者以及不同严重程度抑郁症患者。ROC 分析显示,在截断得分>=50 时,该工具正确分类了 70.4%的样本(ROC 曲线下面积为.76;敏感性为 71.4%;特异性为 67.6%)。
总体而言,我们的结果支持 12 项世界卫生组织残疾评定量表第二版对重度抑郁症的区分有效性,在流行病学研究中非常推荐使用。